Conba Group’s subsidiary Zhejiang Conba Pharmaceutical has completed the sale of 57.3% stake in a pharmaceutical company.

"Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale."

Zhejiang Conba has received a consideration of ¥345.1m ($50.27m) from the stake sale.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Based in China, Zhejiang Conba Pharmaceutical sells medicines and chemical products.

Chabiotech subsidiary CHA Healthcare has reached an agreement to acquire 8.8% stake in Singapore Medical Group.

The stake represents 30 million shares of the target company and costs KRW12.07bn ($10.23m) for the acquirer company.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.